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Abstract 
Xeroderma Pigmentosum is a rare autosomal recessive genetic disorder characterized by defective DNA repair 
leading to clinical and cellular hypersensitivity to ultraviolet radiation and carcinogenic agents. Important clini-
cal features are: intense cutaneous photosensitivity, xerosis, poikiloderma, actinic keratosis, acute burning under 
minimal sun exposure, erythemas, hyperpigmented lentiginous macules, and malignant lesions in sun-exposed 
areas, including basocellular carcinoma, squamous cell carcinoma, and melanoma. There is a great involvement of 
many parts of the body, especially head and neck. The oral manifestations are mainly related to the occurrence of 
malignant tumors in the lips, tongue and buccal mucosa. This paper reports a rare case of Xeroderma Pigmentosum 
in a 41-year-old male presenting mainly dermatological, neurological and ophthalmological involvement. Oral 
implications such as severe oral pain and mouth opening limitation were present due to perioral scars. In addition, 
this paper discuss some important aspects concerning the role of the dental professional management of this entity, 
since XP patients require constant dental care and follow-up in order to control the occurrence of new lesions on 
the lips or inside oral cavity.
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Introduction
Firstly described by Hebra and Kaposi in 1874, Xero-
derma Pigmentosum (XP) is a rare autosomal recessive 
genetic disorder characterized by defective DNA repair 
which leads to clinical and cellular hypersensitivity to 
ultraviolet radiation and other carcinogenic agents (1-6). 
Important clinical features are: intense cutaneous pho-
tosensitivity, xerosis, poikiloderma, actinic keratosis, 
acute burning under minimal sun exposure, erythemas, 
hyperpigmented lentiginous macules, and malignant le-
sions in sun-exposed areas, including basocellular car-
cinoma, squamous cell carcinoma, and melanoma. The 
epidemiology rates of this disorder are varied. Authors 
described different prevalence rates such as: 1:20,000 
in Japan, 1:250,000 in the USA and approximately 2.3 
per million in Western Europe (1-9). Eight forms of the 
disease are recognizable according to the features of the 
molecular defect and clinical aspects (4). High frequen-
cy of consanguinity has been reported. Approximately 
80% of XP have ocular complications, and neurologi-
cal affection occur in approximately 20% of cases (1-6). 
The face and particularly the lips are highly exposed to 
UV radiation and other carcinogenic agents. The aim of 
the present paper is to report a XP case with oral impli-
cations and to discuss the role of the dental professional 
management of this entity.
Case report
A 41-year-old male sought our Service of Stomatology 
complaining about severe oral pain and mouth opening 
limitation due to perioral scars. He presented hyperpig-
mented macules and papules all over the skin (Fig. 1), 
short stature, difficulty in speaking, and tremors during 
writing and moving. Oral hygiene was extremely poor 
due to microstomy (Fig. 2A). During medical history as-
sessment, he reported the removal of three skin lesions 
nine years before; two of them of facial skin (basal cell 
carcinoma and actinic keratosis lichenoides) and ano-
ther one at the chest skin (lentigo simplex) (Fig. 3). The 
patient had consanguineous parents and a brother with 
the same disease. Dental and periodontal problems were 
observed during clinical examination and in panoramic 
radiograph. An ultrasonic cleaning was performed and 
limitation to reach the teeth occurred due to microstomy 
(Fig. 2B). He was instructed to perform proper hygie-
ne of the mouth as well as to keep a rigorous photo-
protection on the lips and the rest of the body by using 
sunscreen moisturizers, wide-brimmed hat and appro-
priate clothing. Furthermore, the patient was referred 
to dermatological, neurological and ophthalmological 
treatment in order to have a multidisciplinary manage-
ment of the case.
Fig. 1. Hyperpigmented macules and papules in the skin 
face, perioral scars and ophthalmic involvement.
Fig. 2. 2A. Perioral scars, dental plaque due to poor oral hy-
giene and microstomy. 2B. Oral condition after dental plaque 
removal using ultrasound.
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Discussion
Skin changes are typical features of XP, such as persis-
tent erythema of the skin. In many cases, these symp-
toms may appear immediately after birth or within the 
following three years, but it may not develop until late 
childhood or may not be recognized until adulthood 
(1-6). Other features of XP are discolorations, weakness 
and fragility, skin scarring, neurological and ocular di-
sorders (10-11). The differential diagnosis of XP should 
be performed with two other syndromes caused by mu-
tations of excision repair pathway genes: Cockayne’s 
syndrome (CS) and Trichothiodystrophy (TTD). Howe-
ver, the occurence of skin cancer associated to high skin 
sensitivity to UV radiation is commonly observed in XP, 
but not in CS or TTD cases (12). The final diagnosis 
of XP can be confirmed by special laboratory tests by 
examining the DNA damage repair in cells from cultures 
exposed to ultraviolet radiation. The most common tests 
are skin biopsy and culture of skin fibroblasts.
De Sanctis Cacchione syndrome has been associated in 
very few patients XP groups A and D, which represents 
the most aggressive disease (13). In the past, any asso-
ciation of XP and neurological disorders was considered 
as De Sanctis-Cacchione syndrome. Currently, the diag-
nostic criteria include severe neurological disease such 
as microcephaly with progressive mental deterioration, 
hyporeflexia or areflexia, choreoathetosis, ataxia, spasti-
city, shortening of Achilles tendon with eventual quadri-
paresis, markedly retarded growth and immature sexual 
development. In addition, patients can present epilepsy, 
progressive sensorineural deafness and abnormal elec-
troencephalographic findings (14). In our case, although 
the patient had some neurological symptoms, the inten-
sity and the signs described above were not enough to 
classify this association.
The oral manifestations are mainly related to the occu-
rrence of malignant tumors in the lips, tongue and buccal 
mucosa (11). In our case, microstomy was a result of 
successive labial plasty for the treatment of actinic chei-
litis. Actinic cheilitis is a potentially malignant lesion 
that affects the lower lip of white patients who were fre-
quently exposed to sun. Pain is a consequence of fibrous 
area that stretches when the patients opens the mouth for 
feeding, speaking, breathing, and for oral hygiene per-
formance. Therefore, the patient has poor hygiene habits 
and consequently, a high rate of dental plaque, caries and 
periodontal disease.
There is no cure for XP. Treatment consists of minimi-
zing exposure to sunlight and regular dermatological 
care, as well as surgery for recurrent tumors excision. 
Fig. 3. 3A,3B- Basal cell carcinoma in facial skin: Blocks of atypical basaloid cells infiltrating the stroma 
(40x, 200x HE);3C-Actinic keratosis lichenoides: epithelial hyperplasia and dysplasia associated with in-
filtrate lichenoid in the dermis (HE 200x); 3D-Lentigo simplex in skin: basal cell layer hyperpigmentation 
associated with an intense loss of melanin pigment in the dermis (400x HE). 
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Early diagnosis and extensive sun protection have the 
potential to prevent skin cancers in XP patients and pro-
long their life expectancy. Although the management of 
XP is complicated due to the difficulty in avoiding daily 
UV exposure, sun protection can be achieved by wearing 
protective clothing, UV-absorbing sunglasses with side 
shields and the use of topic sunblocking agents. UV-ab-
sorbing films and filters can be placed over windows and 
fluorescent or halogen lamps. Self- and dermatological 
skin examinations to monitor any skin changes and en-
sure early detection and treatment of skin cancers should 
be regularly performed. Also, an ophthalmologist must 
be involved since the beginning of the management of 
these patients (6). Eye care consists of sunglasses, arti-
ficial tears, steroid drops, and bland ointment at night. 
These are essential components of a prevention program. 
Patients should be followed up every 3 months (1).
Genetic counseling is also an important component of 
XP patient management, especially in a family that has 
an affected child and is considering having more chil-
dren. XP patients have 1,000 times more chances of 
developing early skin cancer including squamous cell 
carcinoma, basal cell carcinoma and melanoma, less fre-
quently (1-6).
Dental approach is important for the management of XP 
patients with cancer in oral and perioral region. Clinical 
examination carried out regularly by the dentist is man-
datory for the detection of premalignant or malignant le-
sions. Furthermore, it is necessary to establish protocols 
for prophylaxis and topical fluoride application, as well 
as the use of chlorhexidine digluconate 0.12%, aiming 
the homeostasis of the oral environment. The use of 
mouthwashes with high alcohol concentration should be 
avoided because there is an increased risk of developing 
oral cancer in these patients (15). Furthermore, regular 
dental procedures, such as dental extraction, restoration 
and rehabilitation become a challenge for the dentist due 
to difficult access to the oral cavity. The XP patient needs 
a special dental care and a conventional treatment plan is 
not always possible to perform. In our case, the ultraso-
nic cleaning was difficult to perform due to microstomy. 
In some situations, sedation or general anesthesia should 
be considered for regular procedures in Dentistry.
Finally, the main oral manifestations of XP are actinic 
cheilitis, basal cell and squamous cell carcinomas. In 
addition, the presence of scars and lip repair surgery se-
quels are commonly observed, resulting in difficult oral 
care and hygiene. Besides dermatological, ophthalmolo-
gical and neurological management, XP patients require 
constant dental care and follow-up in order to control 
the occurrence of new lesions on the lips or inside oral 
cavity.
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